Publications (10 results)
Please use discretion when following external links; Assaypro cannot guarantee the validity and security of all citation links provided.* Woznichak M et al. (2021) Application of a caprylate/chromatography purification process for production of a high potency rabies immune globulin from pooled human plasma. J Immunol Methods. 499:113164.
* Vitalievna SE (2021) Indicators of Endothelial dysfunction and factors hemostasis in patients with stable and unstable atherosclerotic plaques. Scientific Research Institute of therapy and preventive medicine. Thesis.
* Stryukova EV (2021) Indicator of endothelial dysfunction and factors hemostasis in patients iwht stable and unstable atherosclerotic plates. Federal Research Center Institue of Cytology and Genetics of the Siberian Branch Russian Academy of Sciences. Dissertation.
* Striukova EV et al. (2021) Polymorphisms in the CETP, APOC3 and APOE genes in men with unstable atherosclerotic plaques in the coronary arteries.
* Ragino YI et al. (2019) Association of some hemostasis and endothelial dysfunction factors with probability of presence of vulnerable atherosclerotic plaques in patients with coronary atherosclerosis. BMC Res Notes. 12(1):336.
* Wilmot HV et al. (2018) Establishment of the World Health Organization First International Standard for Factor XII, Plasma, Human.Front Med (Lausanne). 5: 46.
* Wilmot H et al. (2017) Collaborative study on the 1st international standard for blood coagulation factor XII, plasma: assignment of functional (FXII:C) and antigen values (FXII:/AG). WHO/BS/2017.2326
* Li J et al. (2017) Fucosylated chondroitin sulfate oligosaccharides exert anticoagulant activity by targeting at intrinsic tenase complex with low FXII activation: Importance of sulfation pattern and molecular size. Eur J Med Chem. 139:191-200.
* Hess RM (2016) C1 esterase inhibitor mediated protection from acute lung injury. Justus Liebig University Giessen.
* Madsen DE (2013) ELISA for determination of total coagulation factor XII concentration in human plasma. J Immunol Methods. 394(1-2):32-39
